心脉医疗累计回购122.87万股 耗资1.29亿元

Core Viewpoint - The company, Xinmai Medical, has announced a share buyback program, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1] Summary by Relevant Sections - Share Buyback Details - As of August 31, 2025, the company has repurchased a total of 1.2287 million shares through the Shanghai Stock Exchange's centralized bidding system [1] - The highest price paid for the repurchased shares was 120.00 RMB per share, while the lowest price was 84.26 RMB per share [1] - The total amount spent on the buyback is 129 million RMB, excluding transaction fees such as stamp duty and commissions [1]